Back to BlackRock, Inc. BlackRock, Inc.

PVLAPVLA
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Palvella Therapeutics, Inc.

BlackRock, Inc. holds 918,357 shares of PVLA (Palvella Therapeutics, Inc.), worth $140.3M as of 2026-Q2. The position was increased (+33.7% shares). PVLA represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$140.3M

Current Shares

918,357

Total Value Change

+$140.2M

Total Shares Change

+905,419

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
918,357
+33.7%
$140.3M0.0%$152.82
39
2026-Q1
Increased
686,853
+22.9%
$85.6M0.0%$131.51
36
2025-Q4
Increased
559,065
+14.7%
$58.5M0.0%$99.88
34
2025-Q3
Increased
487,616
+9.6%
$30.6M0.0%$62.25
32
2025-Q2
Increased
445,052
+301.8%
$10M0.0%$22.08
45
2025-Q1
Increased
110,758
+756.1%
$3.1M0.0%$28.10
43
2024-Q4
New
12,938
-
$155,2560.0%$12.00
34

Other major holders of PVLA: JENNISON ASSOCIATES LLC, STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC, FRONTIER CAPITAL MANAGEMENT CO LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used